Literature DB >> 20363759

Solution conformation and dynamics of the HIV-1 integrase core domain.

Nicholas C Fitzkee1, James E Masse, Yang Shen, David R Davies, Ad Bax.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) integrase (IN) is a critical enzyme involved in infection. It catalyzes two reactions to integrate the viral cDNA into the host genome, 3' processing and strand transfer, but the dynamic behavior of the active site during catalysis of these two processes remains poorly characterized. NMR spectroscopy can reveal important structural details about enzyme mechanisms, but to date the IN catalytic core domain has proven resistant to such an analysis. Here, we present the first NMR studies of a soluble variant of the catalytic core domain. The NMR chemical shifts are found to corroborate structures observed in crystals, and confirm prior studies suggesting that the alpha4 helix extends toward the active site. We also observe a dramatic improvement in NMR spectra with increasing MgCl(2) concentration. This improvement suggests a structural transition not only near the active site residues but also throughout the entire molecule as IN binds Mg(2+). In particular, the stability of the core domain is linked to the conformation of its C-terminal helix, which has implications for relative domain orientation in the full-length enzyme. (15)N relaxation experiments further show that, although conformationally flexible, the catalytic loop of IN is not fully disordered in the absence of DNA. Indeed, automated chemical shift-based modeling of the active site loop reveals several stable clusters that show striking similarity to a recent crystal structure of prototype foamy virus IN bound to DNA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20363759      PMCID: PMC2878568          DOI: 10.1074/jbc.M110.113407

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  96 in total

1.  Refined solution structure of the C-terminal DNA-binding domain of human immunovirus-1 integrase.

Authors:  A P Eijkelenboom; R Sprangers; K Hård; R A Puras Lutzke; R H Plasterk; R Boelens; R Kaptein
Journal:  Proteins       Date:  1999-09-01

2.  Solution structure of the N-terminal zinc binding domain of HIV-1 integrase.

Authors:  M Cai; R Zheng; M Caffrey; R Craigie; G M Clore; A M Gronenborn
Journal:  Nat Struct Biol       Date:  1997-07

3.  Analysis of the backbone dynamics of the ribonuclease H domain of the human immunodeficiency virus reverse transcriptase using 15N relaxation measurements.

Authors:  R Powers; G M Clore; S J Stahl; P T Wingfield; A Gronenborn
Journal:  Biochemistry       Date:  1992-09-29       Impact factor: 3.162

Review 4.  HIV-1 integrase inhibitors: update and perspectives.

Authors:  Elena A Semenova; Christophe Marchand; Yves Pommier
Journal:  Adv Pharmacol       Date:  2008

Review 5.  Retroviral integrase, putting the pieces together.

Authors:  M D Andrake; A M Skalka
Journal:  J Biol Chem       Date:  1996-08-16       Impact factor: 5.157

6.  Protein backbone angle restraints from searching a database for chemical shift and sequence homology.

Authors:  G Cornilescu; F Delaglio; A Bax
Journal:  J Biomol NMR       Date:  1999-03       Impact factor: 2.835

7.  The DNA-binding domain of HIV-1 integrase has an SH3-like fold.

Authors:  A P Eijkelenboom; R A Lutzke; R Boelens; R H Plasterk; R Kaptein; K Hård
Journal:  Nat Struct Biol       Date:  1995-09

8.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

9.  The solution structure of the amino-terminal HHCC domain of HIV-2 integrase: a three-helix bundle stabilized by zinc.

Authors:  A P Eijkelenboom; F M van den Ent; A Vos; J F Doreleijers; K Hård; T D Tullius; R H Plasterk; R Kaptein; R Boelens
Journal:  Curr Biol       Date:  1997-10-01       Impact factor: 10.834

10.  Resistance mutations in human immunodeficiency virus type 1 integrase selected with elvitegravir confer reduced susceptibility to a wide range of integrase inhibitors.

Authors:  Olivia Goethals; Reginald Clayton; Marcia Van Ginderen; Inge Vereycken; Elisabeth Wagemans; Peggy Geluykens; Koen Dockx; Rudy Strijbos; Veerle Smits; Ann Vos; Geert Meersseman; Dirk Jochmans; Kurt Vermeire; Dominique Schols; Sabine Hallenberger; Kurt Hertogs
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

View more
  17 in total

Review 1.  Structural Insights on Retroviral DNA Integration: Learning from Foamy Viruses.

Authors:  Ga-Eun Lee; Eric Mauro; Vincent Parissi; Cha-Gyun Shin; Paul Lesbats
Journal:  Viruses       Date:  2019-08-22       Impact factor: 5.048

2.  Rigidity and flexibility characteristics of DD[E/D]-transposases Mos1 and Sleeping Beauty.

Authors:  Christopher M Singer; Diana Joy; Donald J Jacobs; Irina V Nesmelova
Journal:  Proteins       Date:  2019-01-10

3.  Measuring rapid hydrogen exchange in the homodimeric 36 kDa HIV-1 integrase catalytic core domain.

Authors:  Nicholas C Fitzkee; Dennis A Torchia; Ad Bax
Journal:  Protein Sci       Date:  2011-02-17       Impact factor: 6.725

4.  Elvitegravir overcomes resistance to raltegravir induced by integrase mutation Y143.

Authors:  Mathieu Métifiot; Nick Vandegraaff; Kasthuraiah Maddali; Alena Naumova; Xuemin Zhang; David Rhodes; Christophe Marchand; Yves Pommier
Journal:  AIDS       Date:  2011-06-01       Impact factor: 4.177

5.  Facile measurement of ¹H-¹5N residual dipolar couplings in larger perdeuterated proteins.

Authors:  Nicholas C Fitzkee; Ad Bax
Journal:  J Biomol NMR       Date:  2010-08-07       Impact factor: 2.835

6.  Characterization of the Copper(II) Binding Sites in Human Carbonic Anhydrase II.

Authors:  Whitnee L Nettles; He Song; Erik R Farquhar; Nicholas C Fitzkee; Joseph P Emerson
Journal:  Inorg Chem       Date:  2015-05-26       Impact factor: 5.165

7.  A symmetric region of the HIV-1 integrase dimerization interface is essential for viral replication.

Authors:  Erik Serrao; Wannes Thys; Jonas Demeulemeester; Laith Q Al-Mawsawi; Frauke Christ; Zeger Debyser; Nouri Neamati
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

8.  Resistance to integrase inhibitors.

Authors:  Mathieu Métifiot; Christophe Marchand; Kasthuraiah Maddali; Yves Pommier
Journal:  Viruses       Date:  2010-06-25       Impact factor: 5.048

9.  Binding modes of diketo-acid inhibitors of HIV-1 integrase: a comparative molecular dynamics simulation study.

Authors:  Meilan Huang; Guy H Grant; W Graham Richards
Journal:  J Mol Graph Model       Date:  2011-04-09       Impact factor: 2.518

10.  Structural and functional role of INI1 and LEDGF in the HIV-1 preintegration complex.

Authors:  Benoit Maillot; Nicolas Lévy; Sylvia Eiler; Corinne Crucifix; Florence Granger; Ludovic Richert; Pascal Didier; Julien Godet; Karine Pradeau-Aubreton; Stéphane Emiliani; Alexis Nazabal; Paul Lesbats; Vincent Parissi; Yves Mely; Dino Moras; Patrick Schultz; Marc Ruff
Journal:  PLoS One       Date:  2013-04-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.